Replies to post #213323 on Anavex Life Sciences Corp (AVXL)

[georgejjl]

Rett Syndrome Association of Australia Inc.- RSAA
September 16 at 4:26 AM ·
Anavex2-73 preliminary data is in, from the US Rett study, and the outlook seems positive. The full report will be presented at the 6th European Rett Congress in Tampre Finland next week, where we will meet with Walter Kaufmann to discuss the Australian Study. This is exciting news although there is still a journey ahead, the data indicates first strong signal to patients with Rett.

We are working on the pediatric sites in Australia and will announce as soon as they have been set up.

Part B of the adult study that will take place at The Alfred in Melbourne will commence in the first week of October.

The RSAA will assist families from around Australia to participate in these clinical trials, it is not too late register, please contact me directly.

https://www.anavex.com/wp-content/uploads/2019/10/Anavex-Presentation-October-2019.pdf

https://www.anavex.com/anavex-life-sciences-announces-preliminary-clinical-efficacy-data-of-its-u-s-phase-2-clinical-trial-of-anavex2-73-in-patients-with-rett-syndrome/

https://www.facebook.com/pg/rettaustralia/posts/

Good luck and GOD bless,